A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment.  TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients.  TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers

Biotechnology

Clinical Trials

Health Care

TORL BioTherapeutics, LLC

Mark Alles

Frank Becking

Heather Adams

Iris Sison

Bilqees Akhtar

Hatem D.

Aran Maree M.d.

Dave Licata

Clinical Operations

People

Jobs